Want to Join Our Team?
Learn about Blue Matter's innovative work experiences, enriching development opportunities, team-oriented "People First" culture, and a lot more.
Insights
Access our ever-expanding library of thought leadership resources for strategic leaders and professionals in biopharma. It’s full of useful content addressing industry challenges, best practices, therapeutic markets, innovative ideas, and forward-looking insights.
Featured Whitepaper
Key Success Factors to Building a Best Practice Medical Affairs Organization
Learn More >
Featured Whitepaper
Building Peak Performance Go-to-Market Operations: Capturing the Value of Medical Innovation in a Fast-Changing Landscape
Learn More >
Blog
Panel Discussion Video: The Renaissance of Psychedelics in CNS Medicine
Blog
My Blue Matter Experience (3) – What words of wisdom would you offer a new team member at Blue Matter?
Blog
Spinal Muscular Atrophy: A Rare Disease with a Complex Treatment Landscape (Part 1)
Blog
My Blue Matter Experience (2) – What’s it like to work on the Blue Matter team?
Presentation
Managed Entry Agreements: Overview and Outlook
Whitepaper
Expanding a Biotech Into Europe: Determining Which Model to Use When Launching Your 1st Product & Building Country Operations
Blog
My Blue Matter Experience (1) – What kind of support and guidance does Blue Matter give to new team members?
Whitepaper
Psychedelics in CNS: Why Interest Is Surging and What to Expect Next
Whitepaper
Keeping Biopharma Up At Night: How the Chronic Insomnia Market Raises Big Questions About Digital Therapeutics
Blog
Expanding a Biotech Business into Europe: Determining Which Model to Use When Launching Your First Product and Building Country Operations in Europe
Blog
How will the change to a more narrow FDA label for Aduhelm (aducanumab) help Biogen?
Blog
Keeping Biopharma Up At Night: How the Chronic Insomnia Market Raises Big Questions About Digital Therapeutics
Whitepaper
Summary of Blue Matter Breakfast Club #9: Is Patient Centricity Always Critical?
Whitepaper
Beyond Linear Drug Development: Leveraging the Constellation Approach in Rare Diseases
Whitepaper
Alzheimer’s Disease: An In-Depth Look at a Formidable Foe
Blog
What challenges could Biogen’s Aduhelm (aducanumab) face as it goes to market?
